We preformed an initial study on cytological tumor markers that suggested additional evaluation of cytological tumor markers CYFRA 21–1, CEA and SCC would be valuable in improving sensitivity in diagnosis of NSCLC in patients undergoing NAB. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.